Medical treatment of pancreatic insufficiency
- PMID: 36518
Medical treatment of pancreatic insufficiency
Abstract
Treatment of exocrine pancreatic insufficiency with the use of eight tablets of pancreatin with meals consisting of 25 g of fat per meal will generally abolish azotorrhea. Although steatorrhea is not totally corrected, satisfactory nutritional status and relative relief of symptoms are usually achieved. For the occasional patient who continues to lose weight or remains symptomatic even after reduction of dietary fat, the addition of cimetidine to the standard pancreatin treatment will usually provide relief from the steatorrhea and alleviate troublesome diarrhea. In certain circumstances in which gastric pH is more than 4 for 1 hour after a meal, altering the dosage schedule to two tablets hourly may be effective in alleviating the steatorrhea. Conversely, in patients whose upper gastrointestinal tract is acidic for long periods postprandially (gastric pH less than 5, duodenal pH less than 4), Pancrease, an enteric-coated preparation, may be effective. In difficult cases in which symptoms and steatorrhea continue, special intraluminal studies need to be performed to ensure that intraluminal conditions are, in fact, present for certain dosage schedules to be effective or that intraluminal conditions have been altered by adjunctive therapy.
Similar articles
-
Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.N Engl J Med. 1977 Jun 9;296(23):1318-22. doi: 10.1056/NEJM197706092962304. N Engl J Med. 1977. PMID: 16213
-
Enzyme replacement therapy of exocrine pancreatic insufficiency in man. Relations between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts.N Engl J Med. 1977 Jun 9;296(23):1314-7. doi: 10.1056/NEJM197706092962303. N Engl J Med. 1977. PMID: 16212
-
Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.Gastroenterology. 1983 Mar;84(3):476-82. Gastroenterology. 1983. PMID: 6549746 Clinical Trial.
-
Current concepts: pancreatic extracts.N Engl J Med. 1969 Jul 24;281(4):201-4. doi: 10.1056/NEJM196907242810406. N Engl J Med. 1969. PMID: 4892805 Review. No abstract available.
-
Treatment of pancreatic exocrine deficiency.World J Surg. 2003 Nov;27(11):1192-5. doi: 10.1007/s00268-003-7237-8. Epub 2003 Oct 13. World J Surg. 2003. PMID: 14534818 Review.
Cited by
-
Controversies in the treatment of exocrine pancreatic insufficiency.Dig Dis Sci. 1982 Jun;27(6):481-4. doi: 10.1007/BF01296724. Dig Dis Sci. 1982. PMID: 6919479 No abstract available.
-
Less common etiologies of exocrine pancreatic insufficiency.World J Gastroenterol. 2017 Oct 21;23(39):7059-7076. doi: 10.3748/wjg.v23.i39.7059. World J Gastroenterol. 2017. PMID: 29093615 Free PMC article. Review.
-
Use of pancreatic Schilling test to determine efficiency of pancreatic enzyme delivery in pancreatic insufficiency.Dig Dis Sci. 1988 Oct;33(10):1226-32. doi: 10.1007/BF01536671. Dig Dis Sci. 1988. PMID: 3168695
-
Predicting exocrine insufficiency following pancreatic resection.J Surg Res. 2010 Nov;164(1):e43-5. doi: 10.1016/j.jss.2010.06.033. Epub 2010 Sep 9. J Surg Res. 2010. PMID: 20850775 Free PMC article. No abstract available.
-
Causes of Exocrine Pancreatic Insufficiency Other Than Chronic Pancreatitis.J Clin Med. 2021 Dec 10;10(24):5779. doi: 10.3390/jcm10245779. J Clin Med. 2021. PMID: 34945075 Free PMC article. Review.